多发性骨髓瘤:当前的临床环境和复合性成本
Kelsey Beck1, Tyler Sandahl2, Sikander Ailawadhi3
1Mayo Clinic Arizona Phoenix, AZ, USA.
多发性骨髓瘤 (MM) 治疗是昂贵的,影响患者和医疗保险. 降低通货膨胀法案可能会降低一些药品的价格,但为了金融可持续性,需要进一步的政策改革.
科学领域:
- 在瘤学瘤学.
- 卫生经济学 卫生经济学
- 公共政策 公共政策
背景情况:
- 多发性骨髓瘤 (MM) 越来越多地被作为一种慢性疾病来管理.
- 毫米治疗是昂贵的,由于长期的维护和多种治疗线路,成本不断上升.
- 老年人群,主要由医疗保险保险,不成比例地受到MM成本的影响.
研究的目的:
- 分析多发性骨髓瘤治疗对患者和医疗保险信托基金的财务影响.
- 评估通货膨胀减缓法案 (IRA) 对MM治疗成本的潜在影响.
- 讨论未来的政策倡议,以确保医疗保险中的MM护理的可持续性.
主要方法:
- 审查当前多发性骨髓瘤治疗环境和相关成本.
- 对医疗保险受益者的人口统计和财务负担的分析.
- 审查"通货膨胀减缓法"有关药品定价的规定.
主要成果:
- MM疗法代表着一个巨大的和日益增长的财务负担.
- 老年人,医疗保险受保人面临着巨大的自付和系统性成本.
- 预计IRA将影响药物定价,可能减少一些MM治疗费用.
结论:
- 虽然IRA可能会提供一些成本减轻,但全面的政策改革至关重要.
- 需要采取进一步的举措,以减轻MM患者的财务毒性.
- 维持医疗保险信托基金需要在高成本治疗管理中进行战略干预.
更多相关视频
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Differentiation of Common Myeloid Progenitor Cells
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
